EB病毒相关淋巴增生性疾病的诊治进展

白血病·淋巴瘤 Pub Date : 2020-03-25 DOI:10.3760/CMA.J.CN115356-20200105-00011

Hang Zhou, Yuhan Ma

{"title":"EB病毒相关淋巴增生性疾病的诊治进展","authors":"Hang Zhou, Yuhan Ma","doi":"10.3760/CMA.J.CN115356-20200105-00011","DOIUrl":null,"url":null,"abstract":"EB virus (EBV) is a potential oncogenic virus. About 95% of healthy people are infected with EBV and carry it for all life. EBV can induce host cells clonization and transformation. About 2% of tumors are related to EBV infection. In recent years, EBV-induced lymphocyte clonal transformation and the diagnosis and treatment of EBV-related lymphoproliferative diseases have got some progress. \n \n \nKey words: \nHerpesvirus 4, human; Lymphoma; Transformation; Immunotherapy; Cellular therapy","PeriodicalId":16246,"journal":{"name":"白血病·淋巴瘤","volume":"29 1","pages":"141-145"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis and treatment progress of EB virus-related lymphoproliferative diseases\",\"authors\":\"Hang Zhou, Yuhan Ma\",\"doi\":\"10.3760/CMA.J.CN115356-20200105-00011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"EB virus (EBV) is a potential oncogenic virus. About 95% of healthy people are infected with EBV and carry it for all life. EBV can induce host cells clonization and transformation. About 2% of tumors are related to EBV infection. In recent years, EBV-induced lymphocyte clonal transformation and the diagnosis and treatment of EBV-related lymphoproliferative diseases have got some progress. \\n \\n \\nKey words: \\nHerpesvirus 4, human; Lymphoma; Transformation; Immunotherapy; Cellular therapy\",\"PeriodicalId\":16246,\"journal\":{\"name\":\"白血病·淋巴瘤\",\"volume\":\"29 1\",\"pages\":\"141-145\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"白血病·淋巴瘤\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.CN115356-20200105-00011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"白血病·淋巴瘤","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN115356-20200105-00011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

EB病毒是一种潜在的致癌病毒。大约95%的健康人感染了EB病毒，并终生携带。EBV可诱导宿主细胞克隆和转化。大约2%的肿瘤与EB病毒感染有关。近年来，EBV诱导的淋巴细胞克隆转化及与EBV相关的淋巴细胞增殖性疾病的诊断和治疗取得了一定进展。关键词：疱疹病毒4型，人；淋巴瘤；转型；免疫治疗；细胞疗法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Diagnosis and treatment progress of EB virus-related lymphoproliferative diseases

EB virus (EBV) is a potential oncogenic virus. About 95% of healthy people are infected with EBV and carry it for all life. EBV can induce host cells clonization and transformation. About 2% of tumors are related to EBV infection. In recent years, EBV-induced lymphocyte clonal transformation and the diagnosis and treatment of EBV-related lymphoproliferative diseases have got some progress. Key words: Herpesvirus 4, human; Lymphoma; Transformation; Immunotherapy; Cellular therapy

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

白血病·淋巴瘤 Medicine-Oncology

自引率

0.00%

发文量

6278

期刊介绍： The JLL is a specialized academic journal that carries articles on hematological malignancies, and mainly about leukemia and lymphoma, involving the fields of medicine, chemistry, biology, etc. The purposes are to reflect the scientific results and the academic trends in the hematological malignancy field. It paid attention on both the basic research and clinical work, but more on the clinical side; on combining popularization with the raising of standards, but more on the raising of standards, in order to provide a field for exchanging experience, inspiring mutually and linking up information for those working for the basic research and clinical diagnosis and treatment in the field of leukemia and lymphoma. It is intended for high and middle ranking medical staffs.